18 September 2012
CYTOO S.A., announces today new results that demonstrate the ability of the Company’s 2D+ Cell Culture Platform to enable two new high content analysis approaches: quantitative density mapping of trafficking compartments and standardized mitochondrial analysis. The results will be presented next week at MiPTec 2012 in Basel by the researchers from the Institut Curie in Paris and Angers University Hospital/INSERM, France.
05 July 2012
CYTOO SA, a company that specializes in cell-based assays, is pleased to introduce 2D+: A Transformational Cell Culture Platform. Cytoo 2D+ Cell Culture Platform is based on the use micro-patterns on plates to drive/control the behavior and localization of cells in cultures.
03 April 2012
CYTOO Inc, the US subsidiary of CYTOO SA, is pleased to announce a partnership with PharmaNest, a contract operations organization who commercializes breakthrough International IND-Enabling Technologies and Services for the US Markets.   
12 December 2011
CYTOO announces new public-private consortium to further develop the power of high throughput, high content RNAi screening through convergence with micropatterning-based cell assays.  
23 November 2011
CYTOO SA, announced today the closing of a series C funding round of USD 10M (EUR 7M). New investors, Sham and Entrepreneurs Fund (EF), led the round. Existing investors AURIGA Partners and Jacques Lewiner, co-founder and president of the supervisory board at CYTOO, also participated.  
26 September 2011
The ETICS project, led by CYTOO in collaboration with Cellectis bioresearch and the CEA, to receive €7.6 million in aid from OSEO. A collaboration to develop highly innovative kits for pharmaceutical research Paris, September 26, 2011 - CYTOO, a company that specializes in cell-based assays (Grenoble, France), has joined up with Cellectis bioresearch, the specialist in genome customization and commercial subsidiary of Cellectis (Alternext: ALCLS), and the CEA, the French Alternative Energies and Atomic Energy Commission, to develop new high-value cell-based assays for drug development and...
24 May 2011
The first edition of the World Cell Race is now officially launched. Organized by a network of researchers in partnership with the American and the French Cell Biology Societies, this unique competition will involve cells coming from labs all around the globe.
27 April 2011
NEEDHAM, Massachusetts (USA) and GRENOBLE (FRA) – April 27, 2011 – The Drug Safety Executive Council (DSEC), an industry membership run by Cambridge Healthtech Associates (CHA), together with CYTOO, a provider of innovative products for the life science research and drug discovery markets with an emphasis in cell based assays, high content analysis and cell screening, today announced a new program as part of DSEC’s Technology Evaluation Consortium. The project will assess the scientific and economic utility of the ReferenceCell™, a technology that provides quantification of cell-based...
17 November 2010
CYTOOplates brings robustness, sensitivity and powerful quantification to cell-based assays and screening Grenoble, France and Framingham, Massachusetts, November 17, 2010 – CYTOO Cell Architects, a developer and marketer of innovative enabling technologies and products for High Content cell Analysis (HCA), today announced the commercial release of CYTOOplates™ 96. This represents the first in a series of products and services integral to CYTOO’s mission of bringing robustness, sensitivity and powerful quantification to cell-based assays and screening. CYTOOplates are ideal for pharma,...
15 June 2010
Top European scientists demonstrate CYTOO’s technology increases sensitivity and speed in cell analysis. Grenoble, France, June 15, 2010 – CYTOO SA, a developer and marketer of innovative enabling technologies and products for high content cell analysis (HCA), today announced the first results from the Institut Curie confirming a major advance in cell analysis made possible by adhesive micropatterns, a technology for which Cytoo holds an exclusive worldwide license. The Institut Curie team demonstrated that a rigorous quantification of the cell-wide internal organization could be...